CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress

Frontiers in Neuroscience

Volumn , Issue 8 MAR, 2014, Pages

  Stengel, Andreas ^a   Taché, Yvette ^b,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Body weight; CRF; Food intake; Stress; Urocortin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; UROCORTIN; UROCORTIN I; UROCORTIN II; UROCORTIN III;

AMBIGUUS NUCLEUS; AMYGDALOID NUCLEUS; ANOREXIA; ANXIETY; ARCUATE NUCLEUS; AREA POSTREMA; BODY TEMPERATURE; BODY WEIGHT; BRAIN CORTEX; CONDITIONED TASTE AVERSION; CRANIAL NERVE; DORSAL RAPHE NUCLEUS; EDINGER WESTPHAL NUCLEUS; EMOTIONAL STRESS; ENERGY BALANCE; ENERGY EXPENDITURE; EXON; FEAR; FEEDING BEHAVIOR; FOOD DEPRIVATION; FOOD INTAKE; GENE DELETION; GROOMING; HIPPOCAMPUS; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; LATERAL HYPOTHALAMUS; LOCOMOTION; LOCUS CERULEUS; MEDIAL AMYGDALA; NONHUMAN; OLFACTORY BULB; OXYGEN CONSUMPTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAPHE NUCLEUS; REVIEW; SOLITARY TRACT NUCLEUS; SPINAL CORD; SPINAL CORD VENTRAL HORN; STRESS; STRIA TERMINALIS; SUBSTANTIA NIGRA; SUPERIOR OLIVARY NUCLEUS; SUPRAOPTIC NUCLEUS; ZONA INCERTA;

EID: 84898029980     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00052     Document Type: Review

References (154)

1. Ardati, A., Goetschy, V., Gottowick, J., Henriot, S., Valdenaire, O., Deuschle, U., et al. (1999). Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay. Neuropharmacology 38, 441-448. doi: 10.1016/S0028-3908(98)00201-9.
2. Asakawa, A., Inui, A., Ueno, N., Makino, S., Fujino, M. A., and Kasuga, M. (1999). Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology 116, 1287-1292. doi: 10.1016/S0016-5085(99)70491-9.
3. Bakshi, V. P., Newman, S. M., Smith-Roe, S., Jochman, K. A., and Kalin, N. H. (2007). Stimulation of lateral septum CRF2 receptors promotes anorexia and stress-like behaviors: functional homology to CRF1 receptors in basolateral amygdala. J. Neurosci. 27, 10568-10577. doi: 10.1523/JNEUROSCI.3044-06.2007.
4. Bale, T. L., Anderson, K. R., Roberts, A. J., Lee, K. F., Nagy, T. R., and Vale, W. W. (2003). Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold. Endocrinology 144, 2580-2587. doi: 10.1210/en.2002-0091.
5. Bale, T. L., and Vale, W. W. (2004). CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 44, 525-557. doi: 10.1146/annurev.pharmtox.44.101802.121410.
6. Basa, N. R., Wang, L., Arteaga, J. R., Heber, D., Livingston, E. H., and Taché, Y. (2003). Bacterial lipopolysaccharide shifts fasted plasma ghrelin to postprandial levels in rats. Neurosci. Lett. 343, 25-28. doi: 10.1016/S0304-3940(03)00312-4.
7. Beckerman, M. A., Van Kempen, T. A., Justice, N. J., Milner, T. A., and Glass, M. J. (2013). Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis. Exp. Neurol. 239, 120-132. doi: 10.1016/j.expneurol.2012.10.009.
8. Benoit, S. C., Thiele, T. E., Heinrichs, S. C., Rushing, P. A., Blake, K. A., and Steeley, R. J. (2000). Comparison of central administration of corticotropin-releasing hormone and urocortin on food intake, conditioned taste aversion, and c-Fos expression. Peptides 21, 345-351. doi: 10.1016/S0196-9781(00)00153-4.
9. Bittencourt, J. C., and Sawchenko, P. E. (2000). Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system. J. Neurosci. 20, 1142-1156.
10. Bittencourt, J. C., Vaughan, J., Arias, C., Rissman, R. A., Vale, W. W., and Sawchenko, P. E. (1999). Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J. Comp. Neurol. 415, 285-312. doi: 10.1002/(SICI)1096-9861(19991220)415:3%3C285::AID-CNE1%3E3.3.CO;2-S.
11. Bonaz, B., and Rivest, S. (1998). Effect of a chronic stress on CRF neuronal activity and expression of its type 1 receptor in the rat brain. Am. J. Physiol. 275, R1438-R1449.
12. Boorse, G. C., and Denver, R. J. (2006). Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides. Gen. Comp. Endocrinol. 146, 9-18. doi: 10.1016/j.ygcen.2005.11.014.
13. Bradbury, M. J., McBurnie, M. I., Denton, D. A., Lee, K. F., and Vale, W. W. (2000). Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. Endocrinology 141, 2715-2724. doi: 10.1210/en.141.8.2715.
14. Brown, M. R., Fisher, L. A., Spiess, J., Rivier, C., Rivier, J., and Vale, W. (1982). Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology 111, 928-931. doi: 10.1210/endo-111-3-928.
15. Buckinx, R., Adriaensen, D., Nassauw, L. V., and Timmermans, J. P. (2011). Corticotrophin-releasing factor, related peptides, and receptors in the normal and inflamed gastrointestinal tract. Front. Neurosci. 5:54. doi: 10.3389/fnins.2011.00054.
16. Calvez, J., Fromentin, G., Nadkarni, N., Darcel, N., Even, P., Tome, D., et al. (2011). Inhibition of food intake induced by acute stress in rats is due to satiation effects. Physiol. Behav. 104, 675-683. doi: 10.1016/j.physbeh.2011.07.012.
17. Cerri, M., and Morrison, S. F. (2006). Corticotropin releasing factor increases in brown adipose tissue thermogenesis and heart rate through dorsomedial hypothalamus and medullary raphe pallidus. Neuroscience 140, 711-721. doi: 10.1016/j.neuroscience.2006.02.027.
18. Cha, S. H., Wolfgang, M., Tokutake, Y., Chohnan, S., and Lane, M. D. (2008). Differential effects of central fructose and glucose on hypothalamic malonyl-CoA and food intake. Proc. Natl. Acad. Sci. U.S.A. 105, 16871-16875. doi: 10.1073/pnas.0809255105.
19. Chagnon, Y. C., Borecki, I. B., Perusse, L., Roy, S., Lacaille, M., Chagnon, M., et al. (2000). Genome-wide search for genes related to the fat-free body mass in the Quebec family study. Metabolism 49, 203-207. doi: 10.1016/S0026-0495(00)91299-X.
20. Challis, B. G., Luan, J., Keogh, J., Wareham, N. J., Farooqi, I. S., and O'Rahilly, S. (2004). Genetic variation in the corticotrophin-releasing factor receptors: identification of single-nucleotide polymorphisms and association studies with obesity in UK Caucasians. Int. J. Obes. Relat. Metab. Disord. 28, 442-446. doi: 10.1038/sj.ijo.0802564.
21. Chao, H., Digruccio, M., Chen, P., and Li, C. (2012). Type 2 corticotropin-releasing factor receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue. Endocrinology 153, 166-176. doi: 10.1210/en.2011-1312.
22. Chatzaki, E., Crowe, P. D., Wang, L., Million, M., Taché, Y., and Grigoriadis, D. E. (2004). CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J. Neurochem. 90, 309-316. doi: 10.1111/j.1471-4159.2004.02490.x.
23. Chen, A., Zorrilla, E., Smith, S., Rousso, D., Levy, C., Vaughan, J., et al. (2006). Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior. J. Neurosci. 26, 5500-5510. doi: 10.1523/JNEUROSCI.3955-05.2006.
24. Chen, A. M., Perrin, M. H., Digruccio, M. R., Vaughan, J. M., Brar, B. K., Arias, C. M., et al. (2005). A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc. Natl. Acad. Sci. U.S.A. 102, 2620-2625. doi: 10.1073/pnas.0409583102.
25. Chen, P., Hover, C. V., Lindberg, D., and Li, C. (2012). Central urocortin 3 and type 2 corticotropin-releasing factor receptor in the regulation of energy homeostasis: critical involvement of the ventromedial hypothalamus. Front. Endocrinol. (Lausanne). 3:180. doi: 10.3389/fendo.2012.00180.
26. Chen, P., Vaughan, J., Donaldson, C., Vale, W., and Li, C. (2010). Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis. Am. J. Physiol. Endocrinol. Metab. 298, E337-E345. doi: 10.1152/ajpendo.00402.2009.
27. Contarino, A., Dellu, F., Koob, G. F., Smith, G. W., Lee, K. F., Vale, W. W., et al. (2000). Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice. Endocrinology 141, 2698-2702. doi: 10.1210/endo.141.7.7653.
28. Cullen, M. J., Ling, N., Foster, A. C., and Pelleymounter, M. A. (2001). Urocortin, corticotropin releasing factor-2 receptors and energy balance. Endocrinology. 142, 992-999. doi: 10.1210/endo.142.3.7989.
29. Currie, P. J., Coscina, D. V., Bishop, C., Coiro, C. D., Koob, G. F., Rivier, J., et al. (2001). Hypothalamic paraventricular nucleus injections of urocortin alter food intake and respiratory quotient. Brain Res. 916, 222-228. doi: 10.1016/S0006-8993(01)02851-7.
30. Dallman, M. F. (2010). Stress-induced obesity and the emotional nervous system. Trends Endocrinol. Metab. 21, 159-165. doi: 10.1016/j.tem.2009.10.004.
31. Daniels, D., Markison, S., Grill, H. J., and Kaplan, J. M. (2004). Central structures necessary and sufficient for ingestive and glycemic responses to Urocortin I administration. J. Neurosci. 24, 11457-11462. doi: 10.1523/JNEUROSCI.2702-04.2004.
32. Dautzenberg, F. M., Higelin, J., Wille, S., and Brauns, O. (2004). Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant. Regul. Pept. 121, 89-97. doi: 10.1016/j.regpep.2004.04.009.
33. Dautzenberg, F. M., Kilpatrick, G. J., Hauger, R. L., and Moreau, J. (2001). Molecular biology of the CRH receptors-in the mood. Peptides 22, 753-760. doi: 10.1016/S0196-9781(01)00388-6.
34. De Fanti, B. A., and Martinez, J. A. (2002). Central urocortin activation of sympathetic-regulated energy metabolism in Wistar rats. Brain Res. 930, 37-41. doi: 10.1016/S0006-8993(01)03401-1.
35. De Groot, J., and Harris, G. W. (1950). Hypothalmic control of the anterior pituitary gland and blood lymphocytes. J. Physiol. 111, 335-346.
36. De Souza, E. B. (1995). Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology. 20, 789-819. doi: 10.1016/0306-4530(95)00011-9.
37. Diaz, I., and Smani, T. (2013). New insights into the mechanisms underlying vascular and cardiac effects of urocortin. Curr. Vasc. Pharmacol. 11, 457-464. doi: 10.2174/1570161111311040009.
38. Dunn, A. J., and Berridge, C. W. (1990). Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Brain Res. Rev. 15, 71-100. doi: 10.1016/0165-0173(90)90012-D.
39. Egawa, M., Yoshimatsu, H., and Bray, G. A. (1990). Preoptic area injection of corticotropin-releasing hormone stimulates sympathetic activity. Am. J. Physiol. 259, R799-R806.
40. Fekete, E. M., Inoue, K., Zhao, Y., Rivier, J. E., Vale, W. W., Szucs, A., et al. (2007). Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval. Neuropsychopharmacology 32, 1052-1068. doi: 10.1038/sj.npp.1301214.
41. Fekete, E. M., Zhao, Y., Szucs, A., Sabino, V., Cottone, P., Rivier, J., et al. (2011). Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress. Br. J. Pharmacol. 164, 1959-1975. doi: 10.1111/j.1476-5381.2011.01512.x.
42. Gourcerol, G., Wang, L., Wang, Y. H., Million, M., and Taché, Y. (2007). Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway. Endocrinology 148, 6115-6123. doi: 10.1210/en.2007-0678.
43. Grace, C. R., Perrin, M. H., Cantle, J. P., Vale, W. W., Rivier, J. E., and Riek, R. (2007). Common and divergent structural features of a series of corticotropin releasing factor-related peptides. J. Am. Chem. Soc. 129, 16102-16114. doi: 10.1021/ja0760933.
44. Grill, H. J., Markison, S., Ginsberg, A., and Kaplan, J. M. (2000). Long-term effects on feeding and body weight after stimulation of forebrain or hindbrain CRH receptors with urocortin. Brain Res. 867, 19-28. doi: 10.1016/S0006-8993(00)02193-4.
45. Guillemin, R., and Rosenberg, B. (1955). Humoral hypothalamic control of anterior pituitary: a study with combined tissue cultures. Endocrinology 57, 599-607. doi: 10.1210/endo-57-5-599.
46. Habib, K. E., Weld, K. P., Rice, K. C., Pushkas, J., Champoux, M., Listwak, S., et al. (2000). Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc. Natl. Acad. Sci. U.S.A. 97, 6079-6084. doi: 10.1073/pnas.97.11.6079.
47. Harris, G. W. (1950). The hypothalamus and endocrine glands. Br. Med. Bull. 6, 345-350.
48. Hauger, R. L., Grigoriadis, D. E., Dallman, M. F., Plotsky, P. M., Vale, W. W., and Dautzenberg, F. M. (2003). International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmaco Rev. 55, 21-26. doi: 10.1124/pr.55.1.3.
49. Heinrichs, S. C., Min, H., Tamraz, S., Carmouche, M., Boehme, S. A., and Vale, W. W. (1997). Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated. Psychoneuroendocrinology 22, 215-224. doi: 10.1016/S0306-4530(97)00030-9.
50. Hillhouse, E. W., and Grammatopoulos, D. K. (2006). The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr. Rev. 27, 260-286. doi: 10.1210/er.2005-0034.
51. Hosoda, H., Kojima, M., and Kangawa, K. (2002). Ghrelin and the regulation of food intake and energy balance. Mol. Interv. 2, 494-503. doi: 10.1124/mi.2.8.494.
52. Hotta, M., Shibasaki, T., Arai, K., and Demura, H. (1999). Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats. Brain Res. 823, 221-225. doi: 10.1016/S0006-8993(99)01177-4.
53. Hsu, S. Y., and Hsueh, A. J. (2001). Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 7, 605-611. doi: 10.1038/87936.
54. Imaki, T., Katsumata, H., Miyata, M., Naruse, M., Imaki, J., and Minami, S. (2001). Expression of corticotropin-releasing hormone type 1 receptor in paraventricular nucleus after acute stress. Neuroendocrinology 73, 293-301. doi: 10.1159/000054646.
55. Inoue, K., Valdez, G. R., Reyes, T. M., Reinhardt, L. E., Tabarin, A., Rivier, J., et al. (2003). Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat. J. Pharmacol. Exp. Ther. 305, 385-393. doi: 10.1124/jpet.102.047712.
56. Jochman, K. A., Newman, S. M., Kalin, N. H., and Bakshi, V. P. (2005). Corticotropin-releasing factor-1 receptors in the basolateral amygdala mediate stress-induced anorexia. Behav. Neurosci. 119, 1448-1458. doi: 10.1037/0735-7044.119.6.1448.
57. Justice, N. J., Yuan, Z. F., Sawchenko, P. E., and Vale, W. (2008). Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system. J. Comp. Neurol. 511, 479-496. doi: 10.1002/cne.21848.
58. Keen-Rhinehart, E., Ondek, K., and Schneider, J. E. (2013). Neuroendocrine regulation of appetitive ingestive behavior. Front. Neurosci. 7:213. doi: 10.3389/fnins.2013.00213.
59. Kimura, T., Amano, T., Uehara, H., Ariga, H., Ishida, T., Torii, A., et al. (2007). Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G903-G910. doi: 10.1152/ajpgi.00066.2007.
60. Kinzig, K. P., Hargrave, S. L., and Honors, M. A. (2008). Binge-type eating attenuates corticosterone and hypophagic responses to restraint stress. Physiol. Behav. 95, 108-113. doi: 10.1016/j.physbeh.2008.04.026.
61. Konishi, S., Kasagi, Y., Katsumata, H., Minami, S., and Imaki, T. (2003). Regulation of corticotropin-releasing factor (CRF) type-1 receptor gene expression by CRF in the hypothalamus. Endocr. J. 50, 21-36. doi: 10.1507/endocrj.50.21.
62. Koob, G. F., and Heinrichs, S. C. (1999). A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res. 848, 141-152. doi: 10.1016/S0006-8993(99)01991-5.
63. Korosi, A., Kozicz, T., Richter, J., Veening, J. G., Olivier, B., and Roubos, E. W. (2007). Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord. J. Comp. Neurol. 502, 973-989. doi: 10.1002/cne.21347.
64. Kostich, W. A., Chen, A., Sperle, K., and Largent, B. L. (1998). Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol. Endocrinol. 12, 1077-1085.
65. Kotz, C. M., Wang, C., Levine, A. S., and Billington, C. J. (2002). Urocortin in the hypothalamic PVN increases leptin and affects uncoupling proteins-1 and-3 in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R546-R551. doi: 10.1152/ajpregu.00436.2001.
66. Kozicz, T., and Arimura, A. (2002). Distribution of urocortin in the rat's gastrointestinal tract and its colocalization with tyrosine hydroxylase. Peptides 23, 515-521. doi: 10.1016/S0196-9781(01)00639-8.
67. Kozicz, T., Yanaihara, H., and Arimura, A. (1998). Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J. Comp. Neurol. 391, 1-10. doi: 10.1002/(SICI)1096-9861(19980202)391:1%3C1::AID-CNE1%3E3.0.CO;2-6.
68. Krahn, D. D., Gosnell, B. A., Grace, M., and Levine, A. S. (1986). CRF antagonist partially reverses CRF-and stress-induced effects on feeding. Brain Res. Bull. 17, 285-289. doi: 10.1016/0361-9230(86)90233-9.
69. Kumar, J., Chuang, J. C., Na, E. S., Kuperman, A., Gillman, A. G., Mukherjee, S., et al. (2013). Differential effects of chronic social stress and fluoxetine on meal patterns in mice. Appetite 64, 81-88. doi: 10.1016/j.appet.2012.12.023.
70. Kuperman, Y., and Chen, A. (2008). Urocortins: emerging metabolic and energy homeostasis perspectives. Trends Endocrinol. Metab. 19, 122-129. doi: 10.1016/j.tem.2007.12.002.
71. Landsberg, L., Saville, M. E., and Young, J. B. (1984). Sympathoadrenal system and regulation of thermogenesis. Am. J. Physiol. 247, E181-E189.
72. Lawrence, A. J., Krstew, E. V., Dautzenberg, F. M., and Ruhmann, A. (2002). The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain. Br. J. Pharmacol. 136, 896-904. doi: 10.1038/sj.bjp.0704783.
73. Levin, B. E. (2006). Metabolic sensing neurons and the control of energy homeostasis. Physiol. Behav. 89, 486-489. doi: 10.1016/j.physbeh.2006.07.003.
74. Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., et al. (2001). Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A. 98, 7570-7575. doi: 10.1073/pnas.121165198.
75. Li, C., Chen, P., Vaughan, J., Blount, A., Chen, A., Jamieson, P. M., et al. (2003). Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. Endocrinology. 144, 3216-3224. doi: 10.1210/en.2002-0087.
76. Li, C., Vaughan, J., Sawchenko, P. E., and Vale, W. W. (2002). Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J. Neurosci. 22, 991-1001.
77. Liapakis, G., Venihaki, M., Margioris, A., Grigoriadis, D., and Gkountelias, K. (2011). Members of CRF family and their receptors: from past to future. Curr. Med. Chem. 18, 2583-2600. doi: 10.2174/092986711795933704.
78. Liu, S., Gao, N., Hu, H. Z., Wang, X., Wang, G. D., Fang, X., et al. (2006). Distribution and chemical coding of corticotropin-releasing factor-immunoreactive neurons in the guinea pig enteric nervous system. J. Comp. Neurol. 494, 63-74. doi: 10.1002/cne.20781.
79. Lovejoy, D. A., and de Lannoy, L. (2013). Evolution and phylogeny of the corticotropin-releasing factor (CRF) family of peptides: Expansion and specialization in the vertebrates. J. Chem. Neuroanat. 54, 50-56. doi: 10.1016/j.jchemneu.2013.09.006.
80. Lutter, M., Sakata, I., Osborne-Lawrence, S., Rovinsky, S. A., Anderson, J. G., Jung, S., et al. (2008). The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat. Neurosci. 11, 752-753. doi: 10.1038/nn.2139.
81. Mano-Otagiri, A., and Shibasaki, T. (2004). Distribution of urocortin 2 and urocortin 3 in rat brain. J. Nippon Med. Sch. 71, 358-359. doi: 10.1272/jnms.71.358.
82. Markovic, D., and Grammatopoulos, D. K. (2010). Characterization of structural determinants of type 1 corticotropin releasing hormone (CRH) receptor signalling properties. Methods Mol. Biol. 634, 285-307. doi: 10.1007/978-1-60761-652-8_21.
83. Mercer, J. G., Lawrence, C. B., and Copeland, P. A. (1992). Corticotropin-releasing factor binding sites undergo axonal transport in the rat vagus nerve. J. Neuroendocrinol. 4, 281-286. doi: 10.1111/j.1365-2826.1992.tb00169.x.
84. Miyata, I., Shiota, C., Chaki, S., Okuyama, S., and Inagami, T. (2001). Localization and characterization of a short isoform of the corticotropin-releasing factor receptor type 2alpha (CRF(2)alpha-tr) in the rat brain. Biochem. Biophys. Res. Commun. 280, 553-557. doi: 10.1006/bbrc.2000.4112.
85. Miyata, I., Shiota, C., Ikeda, Y., Oshida, Y., Chaki, S., Okuyama, S., et al. (1999). Cloning and characterization of a short variant of the corticotropin-releasing factor receptor subtype from rat amygdala. Biochem. Biophys. Res. Commun. 256, 692-696. doi: 10.1006/bbrc.1999.0392.
86. Morin, S. M., Ling, N., Liu, X. J., Kahl, S. D., and Gehlert, D. R. (1999). Differential distribution of urocortin-and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 92, 281-291. doi: 10.1016/S0306-4522(98)00732-5.
87. Ohata, H., Arai, K., and Shibasaki, T. (2002). Effect of chronic administration of a CRF(1) receptor antagonist, CRA1000, on locomotor activity and endocrine responses to stress. Eur. J. Pharmacol. 457, 201-206. doi: 10.1016/S0014-2999(02)02663-8.
88. Ohata, H., and Shibasaki, T. (2004). Effects of urocortin 2 and 3 on motor activity and food intake in rats. Peptides 25, 1703-1709. doi: 10.1016/j.peptides.2004.05.023.
89. Ohata, H., and Shibasaki, T. (2011). Involvement of CRF2 receptor in the brain regions in restraint-induced anorexia. Neuroreport 22, 494-498. doi: 10.1097/WNR.0b013e3283487467.
90. Ohata, H., Suzuki, K., Oki, Y., and Shibasaki, T. (2000). Urocortin in the ventromedial hypothalamic nucleus acts as an inhibitor of feeding behavior in rats. Brain Res. 861, 1-7. doi: 10.1016/S0006-8993(99)02378-1.
91. Onorati, F., Chen-Scarabelli, C., Knight, R., Stephanou, A., Mohanti, B., Santini, F., et al. (2013). Targeting urocortin signaling pathways to enhance cardioprotection: is it time to move from bench to bedside? Cardiovasc. Drugs Ther. 27, 451-463. doi: 10.1007/s10557-013-6468-7.
92. Overman, E. L., Rivier, J. E., and Moeser, A. J. (2012). CRF induces intestinal epithelial barrier injury via the release of mast cell proteases and TNF-alpha. PLoS ONE 7:e39935. doi: 10.1371/journal.pone.0039935.
93. Pelleymounter, M. A., Joppa, M., Carmouche, M., Cullen, M. J., Brown, B., Murphy, B., et al. (2000). Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF. J. Pharmacol. Exp. Ther. 293, 799-806.
94. Pelleymounter, M. A., Joppa, M., Ling, N., and Foster, A. C. (2004). Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin III. Peptides 25, 659-666. doi: 10.1016/j.peptides.2004.01.008.
95. Perrin, M. H., and Vale, W. W. (1999). Corticotropin releasing factor receptors and their ligand family. Ann. N.Y. Acad. Sci. 885, 312-328. doi: 10.1111/j.1749-6632.1999.tb08687.x.
96. Phillips, R. J., and Powley, T. L. (1996). Gastric volume rather than nutrient content inhibits food intake. Am. J. Physiol. 271, R766-R769.
97. Pisarchik, A., and Slominski, A. (2004). Molecular and functional characterization of novel CRFR1 isoforms from the skin. Eur. J. Biochem. 271, 2821-2830. doi: 10.1111/j.1432-1033.2004.04216.x.
98. Pisarchik, A., and Slominski, A. T. (2001). Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J. 15, 2754-2756. doi: 10.1096/fj.01-0487fje.
99. Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., et al. (2001). Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U.S.A. 98, 2843-2848. doi: 10.1073/pnas.051626398.
100. Richard, D., Lin, Q., and Timofeeva, E. (2002). The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance. Eur. J. Pharmacol. 440, 189-197. doi: 10.1016/S0014-2999(02)01428-0.
101. Rivest, S., and Richard, D. (1990). Involvement of corticotropin-releasing factor in the anorexia induced by exercise. Brain Res. Bull. 25, 169-172. doi: 10.1016/0361-9230(90)90270-A.
102. Rybkin, I. I., Zhou, Y., Volaufova, J., Smagin, G. N., Ryan, D. H., and Harris, R. B. (1997). Effect of restraint stress on food intake and body weight is determined by time of day. Am. J. Physiol. 273, R1612-R1622.
103. Saegusa, Y., Takeda, H., Muto, S., Nakagawa, K., Ohnishi, S., Sadakane, C., et al. (2011). Decreased plasma ghrelin contributes to anorexia following novelty stress. Am. J. Physiol. Endocrinol. Metab. 301, E685-E696. doi: 10.1152/ajpendo.00121.2011.
104. Saffran, M., Schally, A. V., and Benfey, B. G. (1955). Stimulation of the release of corticotropin from the adenohypophysis by a neurohypophysial factor. Endocrinology 57, 439-444. doi: 10.1210/endo-57-4-439.
105. Sakai, N., and Yamamoto, T. (1997). Conditioned taste aversion and c-fos expression in the rat brainstem after administration of various USs. Neuroreport 8, 2215-2220. doi: 10.1097/00001756-199707070-00025.
106. Sekino, A., Ohata, H., Mano-Otagiri, A., Arai, K., and Shibasaki, T. (2004). Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats. Psychopharmacology (Berl.) 176, 30-38. doi: 10.1007/s00213-004-1863-1.
107. Selye, H. (1936). A syndrome produced by diverse nocuous agents. Nature 138, 32. doi: 10.1038/138032a0.
108. Selye, H. (1976). Stress in Health and Diseases. Boston, MA; London: Butterworths.
109. Shah, N. S., Pugh, P. C., Nam, H., Rosenthal, D. T., van Wijk, D., Gaszner, B., et al. (2013). A subset of presympathetic-premotor neurons within the centrally projecting Edinger-Westphal nucleus expresses urocortin-1. J. Chem. Neuroanat. 52, 25-35. doi: 10.1016/j.jchemneu.2013.04.004.
110. Shibasaki, T., Yamauchi, N., Kato, Y., Masuda, A., Imaki, T., Hotta, M., et al. (1988). Involvement of corticotropin-releasing factor in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat. Life Sci. 43, 1103-1110. doi: 10.1016/0024-3205(88)90468-7.
111. Sinnayah, P., Blair-West, J. R., McBurnie, M. I., McKinley, M. J., Oldfield, B. J., Rivier, J., et al. (2003). The effect of urocortin on ingestive behaviours and brain Fos immunoreactivity in mice. Eur. J. Neurosci. 18, 373-382. doi: 10.1046/j.1460-9568.2003.02760.x.
112. Smagin, G. N., Howell, L. A., Redmann, S. Jr., Ryan, D. H., and Harris, R. B. (1999). Prevention of stress-induced weight loss by third ventricle CRF receptor antagonist. Am. J. Physiol. 276, R1461-R1468.
113. Smagin, G. N., Howell, L. A., Ryan, D. H., De Souza, E. B., and Harris, R. B. (1998). The role of CRF2 receptors in corticotropin-releasing factor-and urocortin-induced anorexia. Neuroreport 9, 1601-1606. doi: 10.1097/00001756-199805110-00063.
114. Spina, M., Merlo-Pich, E., Chan, R. K., Basso, A. M., Rivier, J., Vale, W., et al. (1996). Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273, 1561-1564. doi: 10.1126/science.273.5281.1561.
115. Stengel, A., Goebel, M., Million, M., Stenzel-Poore, M. P., Kobelt, P., Mönnikes, H., et al. (2009). CRF over-expressing mice exhibit reduced neuronal activation in the arcuate nucleus and food intake in response to fasting. Endocrinology 150, 153-160. doi: 10.1210/en.2008-0723.
116. Stengel, A., Goebel, M., Wang, L., Reeve, J. R., Jr., Taché, Y., and Lambrecht, N. W. (2010). Lipopolysaccharide differentially decreases plasma acyl and desacyl ghrelin levels in rats: Potential role of the circulating ghrelin-acylating enzyme GOAT. Peptides 31, 1689-1696. doi: 10.1016/j.peptides.2010.06.015.
117. Stengel, A., Goebel-Stengel, M., Wang, L., Luckey, A., Hu, E., Rivier, J., et al. (2011). Central administration of pan-somatostatin agonist ODT8-SST prevents abdominal surgery-induced inhibition of circulating ghrelin, food intake and gastric emptying in rats. Neurogastroenterol. Motil. 23, e294-e308. doi: 10.1111/j.1365-2982.2011.01721.x.
118. Stengel, A., and Taché, Y. (2010). Corticotropin-releasing factor signaling and visceral response to stress. Exp. Biol. Med. (Maywood). 235, 1168-1178. doi: 10.1258/ebm.2010.009347.
119. Stengel, A., and Taché, Y. (2012). Yin and Yang-the Gastric X/A-like cell as possible dual regulator of food intake. J. Neurogastroenterol. Motil. 18, 138-149. doi: 10.5056/jnm.2012.18.2.138.
120. Suman-Chauhan, N., Carnell, P., Franks, R., Webdale, L., Gee, N. S., McNulty, S., et al. (1999). Expression and characterisation of human and rat CRF2alpha receptors. Eur. J. Pharmacol. 379, 219-227. doi: 10.1016/S0014-2999(99)00505-1.
121. Tabarin, A., Diz-Chaves, Y., Consoli, D., Monsaingeon, M., Bale, T. L., Culler, M. D., et al. (2007). Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysis. Eur. J. Neurosci. 26, 2303-2314. doi: 10.1111/j.1460-9568.2007.05856.x.
122. Taché, Y., and Bonaz, B. (2007). Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J. Clin. Invest. 117, 33-40. doi: 10.1172/JCI30085.
123. Taché, Y., and Perdue, M. H. (2004). Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol. Motil. 16(Suppl 1), 137-142. doi: 10.1111/j.1743-3150.2004.00490.x.
124. Tanaka, C., Asakawa, A., Ushikai, M., Sakoguchi, T., Amitani, H., Terashi, M., et al. (2009). Comparison of the anorexigenic activity of CRF family peptides. Biochem. Biophys. Res. Commun. 390, 887-891. doi: 10.1016/j.bbrc.2009.10.069.
125. Telegdy, G., and Adamik, A. (2008). Involvement of CRH receptors in urocortin-induced hyperthermia. Peptides 29, 1937-1942. doi: 10.1016/j.peptides.2008.07.028.
126. Telegdy, G., Adamik, A., and Toth, G. (2006). The action of urocortins on body temperature in rats. Peptides 27, 2289-2294. doi: 10.1016/j.peptides.2006.03.022.
127. Turnbull, A. V., and Rivier, C. (1997). Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc. Soc. Exp. Biol. Med. 215, 1-10. doi: 10.3181/00379727-215-44108.
128. Vale, W., Spiess, J., Rivier, C., and Rivier, J. (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213, 1394-1397. doi: 10.1126/science.6267699.
129. Valentino, R. J., Page, M. E., Luppi, P. H., Zhu, Y., Van Bockstaele, E., and Aston-Jones, G. (1994). Evidence for widespread afferents to Barrington's nucleus, a brainstem region rich in corticotropin-releasing hormone neurons. Neuroscience 62, 125-143. doi: 10.1016/0306-4522(94)90320-4.
130. van der Meulen, T., Xie, R., Kelly, O. G., Vale, W. W., Sander, M., and Huising, M. O. (2012). Urocortin 3 marks mature human primary and embryonic stem cell-derived pancreatic alpha and beta cells. PLoS ONE 7:e52181. doi: 10.1371/journal.pone.0052181.
131. Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., et al. (1995). Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378, 287-292. doi: 10.1038/378287a0.
132. Vaughan, J. M., Donaldson, C. J., Fischer, W. H., Perrin, M. H., Rivier, J. E., Sawchenko, P. E., et al. (2013). Posttranslational processing of human and mouse urocortin 2: characterization and bioactivity of gene products. Endocrinology 154, 1553-1564. doi: 10.1210/en.2012-2011.
133. Venihaki, M., Sakihara, S., Subramanian, S., Dikkes, P., Weninger, S. C., Liapakis, G., et al. (2004). Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours. J. Neuroendocrinol. 16, 411-422. doi: 10.1111/j.1365-2826.2004.01170.x.
134. Vetter, D. E., Li, C., Zhao, L., Contarino, A., Liberman, M. C., Smith, G. W., et al. (2002). Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nat. Genet. 31, 363-369. doi: 10.1038/ng914.
135. Wang, L., Basa, N. R., Shaikh, A., Luckey, A., Heber, D., St-Pierre, D. H., et al. (2006). LPS inhibits fasted plasma ghrelin levels in rats: role of IL-1 and PGs and functional implications. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G611-G620. doi: 10.1152/ajpgi.00533.2005.
136. Wang, L., Goebel-Stengel, M., Stengel, A., Wu, S. V., Ohning, G., and Taché, Y. (2011a). Comparison of CRF-immunoreactive neurons distribution in mouse and rat brains and selective induction of Fos in rat hypothalamic CRF neurons by abdominal surgery. Brain Res. 1415, 34-46. doi: 10.1016/j.brainres.2011.07.024.
137. Wang, L., Martinez, V., Rivier, J. E., and Taché, Y. (2001). Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1401-R1410.
138. Wang, L., Martinez, V., Vale, W., and Taché, Y. (2000). Fos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and corticotropin-releasing factor in rats. Brain Res. 855, 47-57. doi: 10.1016/S0006-8993(99)02200-3.
139. Wang, L., Stengel, A., Goebel, M., Martinez, V., Gourcerol, G., Rivier, J., et al. (2011b). Peripheral activation of corticotropin-releasing factor receptor 2 inhibits food intake and alters meal structures in mice. Peptides 32, 51-59. doi: 10.1016/j.peptides.2010.10.017.
140. Weisinger, R. S., Blair-West, J. R., Burns, P., Denton, D. A., McKinley, M. J., Purcell, B., et al. (2000). The inhibitory effect of hormones associated with stress on Na appetite of sheep. Proc. Natl. Acad. Sci. U.S.A. 97, 2922-2927. doi: 10.1073/pnas.040577997.
141. Weitemier, A. Z., and Ryabinin, A. E. (2006). Urocortin 1 in the dorsal raphe regulates food and fluid consumption, but not ethanol preference in C57BL/6J mice. Neuroscience 137, 1439-1445. doi: 10.1016/j.neuroscience.2005.10.021.
142. Wiltshire, S., Hattersley, A. T., Hitman, G. A., Walker, M., Levy, J. C., Sampson, M., et al. (2001). A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am. J. Hum. Genet. 69, 553-569. doi: 10.1086/323249.
143. Wu, S. V., Yuan, P. Q., Lai, J., Wong, K., Chen, M. C., Ohning, G. V., et al. (2011). Activation of Type 1 CRH receptor isoforms induces serotonin release from human carcinoid BON-1N cells: an enterochromaffin cell model. Endocrinology 152, 126-137. doi: 10.1210/en.2010-0997.
144. Wu, S. V., Yuan, P. Q., Wang, L., Peng, Y. L., Chen, C. Y., and Taché, Y. (2007). Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus. Endocrinology 148, 1675-1687. doi: 10.1210/en.2006-0565.
145. Wu, X., Cooper, R. S., Borecki, I., Hanis, C., Bray, M., Lewis, C. E., et al. (2002). A combined analysis of genomewide linkage scans for body mass index from the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am. J. Hum. Genet. 70, 1247-1256. doi: 10.1086/340362.
146. Wypior, G., Jeschke, U., Kurpisz, M., and Szekeres-Bartho, J. (2011). Expression of CRH, CRH-related peptide and CRH receptor in the ovary and potential CRH signalling pathways. J. Reprod. Immunol. 90, 67-73. doi: 10.1016/j.jri.2011.04.009.
147. Yakabi, K., Noguchi, M., Ohno, S., Ro, S., Onouchi, T., Ochiai, M., et al. (2011). Urocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptors. Am. J. Physiol. Endocrinol. Metab. 301, E72-E82. doi: 10.1152/ajpendo.00695.2010.
148. Yuan, P. Q., Million, M., Wu, S. V., Rivier, J., and Taché, Y. (2007). Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats. Neurogastroenterol. Motil. 19, 923-936. doi: 10.1111/j.1365-2982.2007.00978.x.
149. Yuan, P. Q., Wu, S. V., Elliott, J., Anton, P. A., Chatzaki, E., Million, M., et al. (2012a). Expression of corticotropin releasing factor receptor type 1 (CRF1) in the human gastrointestinal tract and upregulation in the colonic mucosa in patients with ulcerative colitis. Peptides. 38, 62-69. doi: 10.1016/j.peptides.2012.07.028.
150. Yuan, P. Q., Wu, S. V., and Taché, Y. (2012b). Urocortins and CRF type 2 receptor isoforms expression in the rat stomach are regulated by endotoxin: role in the modulation of delayed gastric emptying. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G20-G31. doi: 10.1152/ajpgi.00547.2011.
151. Yuan, P. Q., Wu, S. V., Wang, L., and Taché, Y. (2010). Corticotropin releasing factor in the rat colon: expression, localization and upregulation by endotoxin. Peptides 31, 322-331. doi: 10.1016/j.peptides.2009.11.012.
152. Zmijewski, M. A., and Slominski, A. T. (2010). Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim. Pol. 57, 1-13.
153. Zorrilla, E. P., Reinhardt, L. E., Valdez, G. R., Inoue, K., Rivier, J. E., Vale, W. W., et al. (2004). Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity. J. Pharmacol. Exp. Ther. 310, 1027-1034. doi: 10.1124/jpet.104.068676.
154. Zorrilla, E. P., Taché, Y., and Koob, G. F. (2003). Nibbling at CRF receptor control of feeding and gastrocolonic motility. Trends Pharmacol. Sci. 24, 421-427. doi: 10.1016/S0165-6147(03)00177-9.